This study aimed to evaluate the degree of involvement and infiltration of the pelvic lymph glands in endometrial cancer. The retrospective study included patients who were diagnosed with endometrial cancer after exploratory curettage, and who were then referred for surgical treatment with partial or total pelvic lymphadenectomy. We analyzed 99 patients who met the inclusion criteria. Pelvic lymphadenectomy is the treatment of choice in patients with medium and high risk endometrial cancer for disease recurrence. Given the importance of the evaluated issue, it is necessary to perform randomized studies to examine the therapeutic effect of pelvic and paraaortic lymphadenectomy, especially in patients at medium and high risk for recurrence of endometrial cancer.

The aim of this study is to show the correlation between histopathological findings of preoperative exploratory uterine curettage with the result of postoperative histopathological findings in endometrial cancer. Our retrospective study included 386 patients who underwent exploratory curettage and were diagnosed with endometrial cancer, and who were then subjected to surgical treatment for endometrial cancer. The patients were operated on in the period from 2016-2020. at the Gynecology and Obstetrics Clinic “Narodni Front”. Retrospectively, 388 patients who underwent exploratory curettage and were diagnosed with endometrial cancer were included, who were then operated on. The mean age of the patients was 62.7 years and the coincidence of the findings of the histopathological type of endometrial cancer obtained by exploratory curettage and postoperatively was determined in 71.6%, and the coincidence of the histological grade of the cancer in 61.6% of cases. Exploratory uterine cirrhosis is a diagnostic procedure for endometrial cancer. Our results showed that in 4% of cases of endometrial cancers diagnosed by exploratory curettage, they were not found in the postoperative histopathological finding

Gestational diabetes mellitus and maternal overweight and obesity are associated with increased risk for adverse maternal and perinatal outcomes, such as fetal overgrowth. Although most studies addressing the effects of maternal BMI on adverse outcomes include women with GDM, a little is known about associations between maternal BMI and fetal metabolic status evaluated by ultrasonography means. One of the ultrasound parameter of glycemic controlis the measurement of fetal liver length. Prospective study of 385 women with monofetal pregnancies and established risk for GDM underwent mid-trimester ultrasound exam, during which fetal liver length were measured. After exam, body mass index (BMI) was determined for each patient. Each participant underwent 100 g fasting oral glucose challenge test (oGTT) in order to confirm or to exclude diagnosis of GDM. There was a statistically highly significant positive correlation between the BMI and fetal liver length for the entire sample (N=385; p<0.001; R=+0.55) as well in the sample of GDM patients (N=96; p<0.001; R=+0.58) and controls (N=289; p<0.001; R=+0.33). Maternal BMI has impact on fetal liver length assessed by ultrasound exam. This influence is even higher in GDM.